SHOULD ALL PATIENTS WITH ANTI-CENTROMERE ANTIBODIES BE REFERRED FOR A RHEUMATOLOGY ASSESSMENT?

被引：0
|
作者：
Alkoky, Hoda [1 ]
Lazarus, Mark [1 ]
机构：
[1] Southend Univ Hosp, Rheumatol, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.4244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0602
引用
收藏
页码：1395 / 1395
页数：1
相关论文
共 50 条
  • [41] THE TITER OF ANTI-CENTROMERE ANTIBODIES - ITS RELATIONSHIP TO RAYNAUDS-PHENOMENON AND VASCULAR OCCLUSION
    BUCHANAN, RRC
    RIGLAR, AG
    BRITISH JOURNAL OF RHEUMATOLOGY, 1989, 28 (03): : 221 - 226
  • [42] MYOCARDIAL INVOLVEMENT CHARACTERIZES EARLY SYSTEMIC SCLEROSIS WITH ANTI-SCL70 ANTIBODIES AND LONGSTANDING DISEASE WITH ANTI-CENTROMERE ANTIBODIES
    De Santis, M.
    Tonutti, A.
    Motta, F.
    Rodolfi, S.
    Monti, L.
    Francone, M.
    Selmi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 988 - 989
  • [43] Positive Predictive Value of Anti-Centromere and Anti-Scl-70 Antibody Multiplex Assays in a Rheumatology Practice Setting.
    Meier, Svetlana
    Mikuls, Ted R.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S269 - S269
  • [44] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Fritzler, Marvin
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
  • [45] Initial presentation determines clinical entity in patients with anti-centromere antibody positivity
    Tsukamoto, Masako
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (01) : 103 - 107
  • [46] Birth outcomes in Anti-centromere antibody (ACA) - positive patients treated with ART
    Kida, Y.
    Tokoro, M.
    Kitasaka, H.
    Yoshimura, T.
    Fukunaga, N.
    Asada, Y.
    HUMAN REPRODUCTION, 2022, 37 : I548 - I548
  • [47] MULTIPLE PRONUCLEAR ANALYSIS BY IMMUNOFLUORESCENCE STAINING IN HUMAN EMBRYOS DERIVED FROM PATIENTS WITH POSITIVE ANTI-CENTROMERE ANTIBODIES.
    Tokoro, M.
    Ohno, H.
    Aoyagi, N.
    Sonohara, M.
    Tsuiki, M.
    Ishihara, K.
    Funagayama, Y.
    Kida, Y.
    Fukunaga, N.
    Asada, Y.
    FERTILITY AND STERILITY, 2015, 104 (03) : E305 - E305
  • [48] Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study
    Lourido, Lucia
    Ruiz-Romero, Cristina
    Picchi, Flor
    Diz-Rosales, Naomi
    Vilaboa-Galan, Sergio
    Fernandez-Lopez, Carlos
    Pinto Tasende, Jose Antonio
    Perez-Pampin, Eva
    Regueiro, Cristina
    Mera-Varela, Antonio
    Gonzalez, Antonio
    Hambardzumyan, Karen
    Saevarsdottir, Saedis
    Nilsson, Peter
    Blanco, Francisco J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 1101 - 1108
  • [49] The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature
    Hoekstra, E. M.
    Liem, S. I. E.
    Boonstra, M.
    Fehres, C. M.
    Schoones, J. W.
    Huizinga, T. W. J.
    de Vries-Bouwstra, J. K.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [50] Systemic lupus erythematosus with anti-centromere antibodies: An infrequent finding without scleroderma related features
    Cabrera, Carmen M.
    MEDICINA CLINICA, 2016, 147 (07): : 322 - 324
12345